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Available online 4 November 2016Background: Previous studies of mostly Western women have reported inconsistent ﬁndings on the association
between age at menarche and risk of cardiovascular disease (CVD). Little is known about the association in
China where there has been a large intergenerational decrease in women's mean age at menarche.
Methods: The China Kadoorie Biobank recruited 302,632 women aged 30–79 (mean 50.5) years in 2004–8 from
10 diverse regional sites across China. During 7 years follow-up, 14,111 incident cases of stroke, 14,093 of coro-
nary heart disease (CHD), and 3200 CVD deaths were reported among 281,491womenwho had no prior history
of CVD at baseline. Cox regression yielded adjusted hazard ratios (HRs) relating age at menarche to CVD risks.
Results: Themean (SD) age ofmenarchewas 15.4 (1.9) years, decreasing from 16.2 (2.0) amongwomen born be-
fore 1940 to 14.7 (1.6) for those born during the 1960s–1970s. The patterns of association between age at men-
arche and CVD risk appeared to differ between different birth cohorts, with null associations in older generations
but U-shaped or weak positive associations in younger women, especially those born after the 1960s. After min-
imizing the potential confounding effects from major CVD risk factors, both early and late menarche, compared
with menarche at age 13 years, were associated with increased risk of CVDmorbidity and mortality, which was
more pronounced in younger generations.
Conclusion: Among Chinese women the associations between age at menarche and risk of CVD differed by birth
cohort, suggesting other factors may underpin the association.







Cardiovascular disease (CVD) is a leading cause of mortality and
morbidity throughout the world, including China [1]. The incidence ofit and Epidemiological Studies
iversity of Oxford, Oxford OX3
chool of Public Health, Peking
mlee@vip.163.com (L. Li).
land Ltd. This is an open access articlCVD is low in women of reproductive age but rises rapidly after meno-
pause, leading to the ‘oestrogen hypothesis’which suggests that endog-
enous oestrogen protects women of reproductive age from CVD. [2,3]
Menarche, deﬁned as theﬁrstmenstrual period signiﬁes the onset of re-
productive capacity, and its timingmay have important health implica-
tions, either directly or indirectly.
There is evidence that earlymenarche is associatedwith certain CVD
risk factors, such as increased bodymass index (BMI) [4,5]. Several stud-
ies of mostly Western populations have examined the association of
early menarche with CVD, but the ﬁndings have been inconsistent,
with some showing no associations, while others reported a U-shapede under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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of women had age atmenarche before or during the early teenage years
[5–8]. Evidence from Asian populations, particularly from Chinese
women, where the mean age at menarche tended to be later compared
with their counterparts in theWest, is limited [9–11]. A few small stud-
ies in Asia, where most women were born during the ﬁrst half of 20th
century and had experienced their ﬁrst menstrual period during their
late teenage years (mean age at menarche over 16 years) suggested
that the patterns of associationmay differ from that inWestern popula-
tions, for reasons that are not properly understood [10,11]. In China
there has been a rapid change in women's reproductive patterns in
recent decades, [12] which may well have long-term health conse-
quences. We examined the association between age at menarche and
risk of major CVDs and investigated intergenerational differences in
300,000 women from the China Kadoorie Biobank (CKB) prospective
study who were born during the 1920s–1970s.
2. Methods
2.1. Study population
Detailed information about the CKB study design andprocedures has
been reported previously [13]. Brieﬂy, the baseline survey took place
during 2004–8 in 10 geographically deﬁned areas across China Overall,
512, 891 individuals (302,632women) aged 30–79 yearswere enrolled.
All participants provided written consent for follow-up. International,
national, and local ethics approval was obtained.
2.2. Data collection
At study assessment clinics, trained health workers administered
laptop-based questionnaires on socio-demographic status, dietary and
other lifestyle habits, personal and family history. A range of physical
measurements, including blood pressure and anthropometry, were un-
dertaken for each participant alongwith collection of a blood sample for
long-term storage. Every 4–5 years a 5–6% random sample of surviving
participants was resurveyed.
2.3. Women's reproductive history
Women's reproductive history included age atmenarche, parity, age
at birth and breastfeedingduration for each live birth,menopause status
and age at menopause for post-menopausal women, and history of oral
contraceptive (OC) use, hysterectomy, ovarian or breast surgery.
2.4. Follow-up for mortality and morbidity
Since recruitment, participants have been followed-up formorbidity
andmortality through linkagewith regional disease and death registers,
and for all hospitalized events through electronic data linkage with the
nationwide health insurance system. Causes of death are sought chieﬂy
fromofﬁcial death certiﬁcates, supplemented, if necessary, by reviewing
medical records. To minimize losses to follow-up, active follow-up is
also performed annually [13]. In the present study the main outcome
measures were CVD deaths (ICD-10: I00-I99), fatal or non-fatal CHD
(I20-I25) and stroke (I60-I69). Subtypes of stroke, i.e. ischemic (I63)
or hemorrhagic stroke (I61) were also assessed.
2.5. Statistical analyses
Among 302,632 women recruited at baseline, we excluded 2012
women with inconsistent or extreme data for any reproductive factor,
and 19,129womenwho had a prior history of CVD, cancer or oophorec-
tomy. After these exclusions, 281,491 women remained in the main
analyses.Cox proportional hazards models were used to estimate hazard
ratios (HRs) for CVD in relation to age at menarche, stratiﬁed by region,
age at risk, and education (Model 1). Further adjustments were made
(Model 2) for conventional CVD risk factors, including systolic blood
pressure, household income, smoking, alcohol drinking, BMI, physical
activities (metabolic equivalent tasks [METs-hrs/day]) [14], self-
reported or screen-detected diabetes, and leg length as a marker of
pre-pubertal growth [15]. To minimize potential confounding by other
reproductive factors [10,16–19], we additionally adjusted for meno-
pause status, parity, age at ﬁrst birth, breastfeeding duration and OC
use (Model 3). We also conducted analyses among women who had
never smoked or consumed alcohol, had no diabetes at baseline and
never used OCs (Model 4). Given the striking temporal trends in repro-
ductive factors we reported previously [12], further analyses were done
by birth cohort to assess whether the associations between age at
menarche and CVD risk varied signiﬁcantly by birth cohort. The 95%
conﬁdence interval (CI) for each log HR was estimated using the
‘ﬂoating absolute risk’ method [20]. To correct for regression dilution
bias related to reporting error in age at menarche [21,22], HRs in the
groups determined at baselinewere plotted against the usual menarche
age, i.e. the mean value of menarche age in that group at the 2008
resurvey. Analyses were performed using SAS version 9.3 and R version
3.0.1.
3. Results
Among the 281,491 women included, the mean (SD) age was 50.5
(10.3) years, 43%were urban residents, few ever smoked (2%), drank al-
cohol regularly (2%) or used OCs (10%) but nearly all had given birth
(98.7%) and breastfed their children (97.3%) (Table 1). Overall the
mean age atmenarchewas 15.4 (1.9) years, with a large decrease across
generations, from 16.2 (2.0) years among women born before 1950 to
15.6 (1.9) years in the 1950s and 14.7 (1.7) years in those born after
1959.
Compared to womenwith a later onset of menarche, those who had
early menarche (i.e. ≤12 years) were, on average, younger, more likely
to be urban residents, better educated, to have higher income, higher
mean BMI and blood pressure, shorter leg length, more likely to be
physically inactive and to have self-reported diabetes.Womenwith ear-
lier menarche also tended to have a later age at ﬁrst birth, shorter dura-
tion of breastfeeding, earlier age at menopause and higher number of
reproductive years than women with later menarche (Table 1).
During 2.0 million women-years of follow-up, 14,111 participants
had stroke (including 11,173 ischemic, 2142 hemorrhagic) 14,093 had
CHD (including 1177 acute myocardial infarction), and 3200 died
from CVD.
3.1. Age at menarche and stroke
Overall, age at menarche was not signiﬁcantly associated with total
stroke (Fig. 1) or stroke subtypes (web-Figure), after adjustment for
lifestyle risk factors both overall and in subgroups of women deﬁned
by residential area, overweight status or education level (web-Tables 1,
2). Further adjustment for other reproductive factors did not alter the
results substantially. However, the association appeared to vary consid-
erably by birth cohort. Early menarche was associated with 16% lower
risk of stroke among women born during the 1920s–1940s, but con-
versely with 18% increased risk among women born in the 1950, com-
pared with menarche at age 13–14 years. No association of stroke
with later ages at menarche was observed in women born before
1959. Among women who were born in the 1960s–1970s, however,
there was a U-shaped association with HRs of 1.24 (1.05–1.47), 1.00
(0.92–1.09) 1.12 (1.03–1.21) and 1.21 (1.07–1.37), respectively for
those with age of menarche at ≤12, 13–14, 15–16 and ≥17 years
(Pinteraction = 0.02) (Table 2). This birth cohort effect may contribute to
the different associations observed in subgroups deﬁned bymenopause
Table 1
Baseline characteristics of study population by age at menarche.
Overall
Age at menarche
≤12 13 14 15 16 17 ≥18
Number of subjects 281,491 15,251 32,426 46,984 53,132 52,286 39,817 41,595
Mean age, years 50.5 46.0 46.4 47.3 49.5 51.4 53.3 56.0
Socio-economic and lifestyle factors
Urban resident, % 43.2 50.8 50.3 44.2 41.8 41.5 41.7 39.0
Income N20,000 CNY/year, %a 40.7 44.8 44.3 42.5 41.4 39.5 38.3 35.6
No formal school education, % 25.4 23.3 21.8 22.2 24.2 25.5 27.0 30.8
Current regular smoker, % 2.3 2.4 2.2 2.2 2.3 2.3 2.4 2.3
Weekly regular drinker, % 2.1 2.4 2.0 2.0 1.9 2.0 2.2 2.4
BMI, kg/m2 23.7 24.5 24.2 24.0 23.8 23.6 23.5 23.2
Overweight (25–29.9 kg/m2), % 28.8 33.9 32.8 30.7 29.2 28.1 26.7 25.0
Obese (≥30 kg/m2), % 4.6 7.3 6.0 5.3 4.7 4.1 3.7 3.5
Leg length, cm 71.0 70.5 70.6 70.8 70.9 71.2 71.3 71.2
Total physical activity, MET-h/day 20.9 20.7 20.8 20.7 20.7 21.0 21.0 21.1
SBP, mmHg 129.4 130.5 130.1 129.9 129.7 129.3 128.7 128.5
Had prior diabetes, % 5.5 7.1 6.4 6.2 5.8 5.5 5.0 4.8
Ever use of oral contraceptive pill, % 9.8 10.5 10.4 10.3 10.0 9.8 9.7 9.1
Reproductive factors
Nulliparous, % 1.3 1.4 1.5 1.4 1.2 1.1 1.1 1.2
Number of live birthsb 2.2 2.1 2.2 2.2 2.2 2.2 2.2 2.2
Parity ≥3 children, % 31.5 28.7 29.3 30.4 31.2 32.3 32.9 33.4
Age at ﬁrst birth, yearsb 23.4 23.3 23.3 23.3 23.2 23.2 23.3 23.7
Never breastfed, %b 2.7 3.6 3.3 3.0 2.7 2.3 2.2 2.4
Breastfeeding duration per child, monthsb 14.6 13.9 14.0 14.2 14.4 14.7 14.9 15.2
Pre-menopause at baseline, % 44.6 44.9 45.3 45.8 45.2 44.4 44.0 42.7
Age at menopause, yearsc 48.3 47.5 48.0 48.1 48.2 48.3 48.4 48.5
Reproductive years, yearsc 32.3 35.6 35.0 34.1 33.2 32.3 31.4 29.9
a CNY: Chinese Yuan, 1 CNY = 0.15 US$ at Dec. 2015.
b Among parous women only.
c Among post-menopausal women only.
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among pre-menopausal women (median birth year of 1964), while a
null association among post-menopausal women (median birth year
of 1949) (Pinteraction = 0.007). After excluding women with major CVD
risk factors (Model 4), both early and later menarche were associated
with increased risks of stroke, compared with women with menarche
at age 13 years (web-Table 1). However, this U-shaped association
was seen in younger generations but not in older women (data not
shown).592
1277
1977 2577 2702 2190 2523
1.07
1.00
1.04 1.06 1.04 1.03 1.01


































































Fig. 1.Adjusted hazard ratios for stroke, CHD and CVD deaths associatedwith age atmenarche. A
pressure, household income, smoking, alcohol drinking, BMI, physical activities (MET), prior-dia
and plotted against mean usual age atmenarche level in each category. Squares represent the H
corresponding 95% conﬁdence intervals (CIs). Numbers above CIs are of HRs and those below3.2. Age at menarche and CHD
No association was observed between age at menarche and risk of
CHD overall (Fig. 1) or in subgroups of women (web-Table 2). There
was no clear association between age at menarche and CHD risk
among women born before 1959, however among those born during
the 1960s–1970s risk of CHD increased slightly with increasing age at
menarche (Table 2). Both early and latemenarche, comparedwithmen-





















































nalyseswere stratiﬁed by age and study area, and adjusted for education,measured blood
betes status and leg length. The hazard ratios (HRs) are plotted on a ﬂoating absolute scale,
R with area inversely proportional to the variance of the log HR. Vertical lines indicate the
are the numbers of studied events.
Table 2
Adjusted hazard ratios for stroke, CHD and CVD death associated with age at menarche by birth cohorta.
Outcome Birth cohort Events/HRs
Age at menarche
≤12 13–14 15–16 ≥17
Stroke 1920s–1930s No. events 93 722 1426 1369
HR (95%CI) 0.84 (0.68, 1.03) 1.00 (0.93, 1.08) 1.00 (0.95, 1.06) 1.01 (0.96, 1.07)
1940s No. events 116 876 1681 1885
HR (95%CI) 0.83 (0.69, 1.00) 1.00 (0.93, 1.07) 1.02 (0.97, 1.06) 0.95 (0.90, 0.99)
1950s No. events 248 1120 1590 1196
HR (95%CI) 1.18 (1.04, 1.33) 1.00 (0.94, 1.06) 1.01 (0.96, 1.06) 0.96 (0.90, 1.02)
1960s–1970s No. events 135 536 582 263
HR (95%CI) 1.24 (1.05, 1.47) 1.00 (0.92, 1.09) 1.12 (1.03, 1.21) 1.21 (1.07, 1.37)
CHD 1920s–1930s No. events 97 675 1322 1207
HR (95%CI) 0.98 (0.80, 1.19) 1.00 (0.93, 1.08) 1.02 (0.97, 1.08) 1.01 (0.95, 1.07)
1940s No. events 117 878 1541 1835
HR (95%CI) 0.86 (0.72, 1.03) 1.00 (0.93, 1.07) 0.91 (0.87, 0.96) 0.91 (0.87, 0.96)
1950s No. events 211 1164 1579 1270
HR (95%CI) 0.99 (0.86, 1.13) 1.00 (0.94, 1.06) 0.96 (0.91, 1.01) 0.98 (0.93, 1.04)
1960s–1970s No. events 142 737 753 326
HR (95%CI) 0.97 (0.82, 1.15) 1.00 (0.93, 1.08) 1.03 (0.96, 1.11) 1.08 (0.96, 1.20)
CVD death 1920s–1940s No. events 67 432 950 914
HR (95%CI) 1.02 (0.80, 1.29) 1.00 (0.91, 1.10) 1.10 (1.03, 1.17) 0.99 (0.93, 1.06)
1950s–1970s No. events 33 169 261 202
HR (95%CI) 0.98 (0.70, 1.38) 1.00 (0.86, 1.17) 1.10 (0.97, 1.23) 1.10 (0.95, 1.27)
a Cox model stratiﬁed by age and region and adjustment for education level, measured blood pressure, household income, smoking, alcohol drinking, BMI, physical activities (MET),
prior-diabetes status and leg length.
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education, BMI and menopausal status (web-Tables 1,2).
3.3. Age at menarche and CVD deaths
As for stroke and CHD risk, overall there was a null association be-
tween age at menarche and risk of CVD mortality (Fig. 1). In further
analyses by birth cohort, there was no association between age at men-
arche and risk of CVD death in those born in the 1920s–1940s, but a
weak positive association was present in younger women born in the
1950s–1970s (Table 2). Either early or later menarche was associated
with increased risks of CVD death inwomenwith nomajor CVD risk fac-
tors, with adjusted HRs of 1.37 (1.03–1.81), 1.00 (0.81–1.23), 1.22
(1.05–1.41), 1.35 (1.21–1.51), 1.29 (1.16–1.44), 1.26 (1.11–1.42) and
1.24 (1.11–1.39) for those with menarche age at b13, 13, 14, 15, 16,
17 and ≥18 respectively. This U-shaped association was seen in sub-
groups deﬁned by birth cohort and other CVD risk factors, although
the numbers of cases were small (data not shown).
4. Discussion
This is the ﬁrst large prospective study of the association between
age at menarche and the risk of CVD in China. Among about 300,000
womenwhowere recruited from the general communities in 10diverse
regions of China, the mean age of menarche showed large intergenera-
tional decreases. The patterns of association between age at menarche
and CVD risks appeared to differ somewhat between different birth co-
horts, with null associations in older generations but U-shaped or weak
positive associations in younger women, especially those born after the
1960s. Afterminimizing potential confounding frommajor CVD risk fac-
tors, both early and late menarche were associated with increased risk
of CVD morbidity and mortality, compared with menarche at age 13–
14 years. Our ﬁndings suggest that among Chinese women the risk of
CVD associated with pubertal timing may be inﬂuenced by factors
such as socio-economic status, adiposity, and blood pressure.
Previous studies of mostly Western women born before the 1960s
with mean age at menarche below 13 years, have reported inconsistent
ﬁndings on the association between age at menarche and CVD risks [2,
5–9,19,23]. A recent report from the UK Million Women Study (MWS)
of 1.2 million post-menopausal British women born between 1930–
1950s with 73,378 CHD and 25,426 stroke cases, showed a clear U-shaped association for both diseases. In that study, women who had
menarche ≤10 years or ≥17 years both had about 25% excess risk for
CHD and 15% excess risk for stroke, compared with those with menar-
che age of 13 years. [7] A similar U-shaped association between age at
menarche and prevalent CVD was also seen among 250,000 women in
the UK-Biobank cohort [23]. However, neither of these studies investi-
gated birth cohort effects. In our study, we ﬁnd a similar U-shaped asso-
ciation for stroke among women born after the 1960s, who, compared
with older generations, had more similar characteristics on both life-
style and reproductive factors as in Western women.
Limited data from other studies in China also suggested different
patterns of association of age at menarche with CVD by birth cohort.
In the Shanghai Women's Health study of 31,955 post-menopausal
women (most born before the 1940s), there was no association be-
tween age at menarche and total CVD and CHD mortality. [24] In con-
trast, the Shanghai female textile workers study of 267,400 women
(60% born after 1950) found that early menarche (b14 vs. N14 years)
was associated with 44% increased risk of CHD (1.44 [1.00–2.05]), but
no excess stroke mortality [10]. Compared with women born in the
1920s–30s in China, younger generations tended to be much better ed-
ucated, less likely to smoke and drink alcohol, more physically active
and to have fewer children and shorter breastfeeding duration (web-
Table 3). It is likely that the pattern of reproductive factors and their
interplay with lifestyle factors may affect subsequent associations of re-
productive factors with CVD risks. Indeed, when we excluded the
confounding effects from somemajor CVD risk factors, U-shaped associ-
ations between age atmenarche andCVD riskwere present,whichwere
more pronounced in younger generations. The rapid industrialisation of
China with increasing wealth has resulted in increased prevalence of
CVD and CVD risk factors, increasingly mirroring those seen inWestern
populations. Women who experienced early menarche are likely to
have higher BMI, higher blood pressure, increased risk of insulin resis-
tance, and metabolic syndrome [5]. If the increased risk of stroke with
early menarche seen in our study, particularly in the younger women,
was casual, the shift towards younger age at menarche over time
would result in an increased burden of stroke in China over the next
few decades; on the other hand, preventing the risk factors of early
age at menarche, such as childhood obesity, could have public health
beneﬁts.
Themechanisms underlying variation in the timing of menarche are
unclear. Genome-wide association studies on the timing of menarche
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associated with age at menarche identiﬁed which also overlap some-
what with genes implicated in BMI and various diseases. [25–27] This
suggests there may be shared causal pathways between age at menar-
che and adiposity inﬂuencing disease risks. However, limited genetic
evidence has been reported from Asian women.
Our study has a number of strengths including large sample size,
good quality and completeness of data collected and wide range of re-
productive history information. Moreover, there was high repeatability
of age at menarche (i.e. intra-class correlation coefﬁcient of 0.84 be-
tween the baseline survey and the resurvey) and a high accuracy
(~90%) of the reported diagnoses based on our ongoing CVD outcome
adjudication. Several limitations need to be taken into account. Lack of
information on childhood adiposity precluded assessment of the effects
of adiposity at an earlier age,which has been closely associatedwith pu-
bertal timing [5]. However, adiposity in later adulthood, whichwewere
able to adjust for, may bemore likely to indicate long-term exposure to
being overweight, and thusmay bemore important when assessing the
increased CVD risk associated with early menarche. Residual confound-
ing from other unknown risk factors may exist due to the observational
nature of the study.
The different associations between age at menarche and CVD risk
among different populations and between birth cohorts within a popu-
lation, as observed in our study, have implications for future research.
Findings from one population may not be applicable to another that
has a different distribution of age atmenarche, thus, systematic reviews
or meta-analyses on this topic should take into account these varying
distributions in populations fromdifferent studies. Further investigation
from both observational and genetic studies is needed on the underly-
ing reasons for differences in the patterns of association between age
at menarche and disease risk, and interplay with related generational,
life-style or other reproductive factors.
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